Showing results (21-30 of 113) with videos related to
Sort By:
Pageof 12
Scientific Reports|December 6, 2019
Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patientsQingtao Ni, Ines Stevic, Chi Pan, et al.Molecular and Clinical Oncology|December 2, 2015
Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive functionCharlotte VON Bülow, Leticia Oliveira-Ferrer, Thomas Löning, et al.Scientific Reports|August 30, 2018
Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patientsQingtao Ni, Ines Stevic, Chi Pan, et al.Molecular Oncology|August 15, 2018
Exosomal microRNAs as tumor markers in epithelial ovarian cancerChi Pan, Ines Stevic, Volkmar Müller, et al.Journal of Experimental & Clinical Cancer Research : CR|December 31, 2008
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathwayLeticia Oliveira-Ferrer, Jessica Hauschild, Walter Fiedler, et al.Cognitive, Affective & Behavioral Neuroscience|August 3, 2021
Unveiling the neural underpinnings of optimism: a systematic reviewFatima Erthal, Aline Bastos, Liliane Vilete, et al.BMC Cancer|January 8, 2024
Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosisJil Weigelt, Mariam Petrosyan, Leticia Oliveira-Ferrer, et al.Journal of Cancer Research and Clinical Oncology|September 8, 2023
Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancerAnnabelle Volk, Karen Legler, Fabienne Hamester, et al.Breast Cancer Research and Treatment|October 25, 2019
Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patientsMalgorzata Banys-Paluchowski, Karin Milde-Langosch, Tanja Fehm, et al.Molecular Oncology|June 1, 2021
Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancerYi Ding, Vera Labitzky, Karen Legler, et al.Pageof 12